How is geriatric assessment used in clinical practice for older adults with cancer? A survey of cancer providers by the American Society of Clinical Oncology

W Dale, GR Williams, A R. MacKenzie… - JCO oncology …, 2021 - ascopubs.org
PURPOSE: For patients with cancer who are older than 65 years, the 2018 ASCO Guideline
recommends geriatric assessment (GA) be performed. However, there are limited data on …

Impact of comprehensive geriatric assessment on the risk of adverse events in the older patients receiving anti-cancer therapy: a systematic review and meta-analysis

MH Chuang, JY Chen, WW Tsai, CW Lee… - Age and …, 2022 - academic.oup.com
Background to assess the efficacy of comprehensive geriatric assessment (CGA) for
preventing treatment-related toxicity in older people undergoing non-surgical cancer …

[HTML][HTML] Circulating Osteopontin Predicts Clinical and Radiological Response in First-Line Treatment of Advanced Non-Small Cell Lung Cancer

D Ramoni, S Coco, G Rossi, C Dellepiane, E Bennicelli… - Lung, 2024 - Springer
Purpose Pembrolizumab-based regimens are conditioned by the expression of PD-L1, but
durable response rate is limited by innate and acquired resistance mechanisms. Here, we …

Oncology care providers' perceptions and anticipated barriers regarding the use of geriatric assessment in routine clinic practice: A mixed-methods study

S Sattar, KR Haase, M Puts, M Iddrisu… - Journal of Geriatric …, 2024 - Elsevier
Introduction Geriatric assessment (GA) is currently not a standard of cancer care across
Canada. In the Canadian province of Saskatchewan, there are no known formal geriatric …

Estimating survival time in older adults receiving chemotherapy for advanced cancer

EB Moth, P Blinman, N Stefanic, V Naganathan… - Journal of Geriatric …, 2020 - Elsevier
Purpose We determined the accuracy of oncologists' estimates of expected survival time
(EST) for older adults with advanced cancer, and explored predictors of survival from a …

Analysis of factors affecting progression-free survival of first-line chemotherapy in older patients with advanced gastrointestinal cancer

J Nakazawa, M Kawahira, M Kawahira… - Journal of Geriatric …, 2021 - Elsevier
Objectives Few studies have investigated factors influencing the efficacy of chemotherapy in
older patients with cancer. This study aimed to evaluate the usefulness of G8, geriatric …

[PDF][PDF] Predicting toxicity of platinum and taxane-based chemotherapy in older patients with gynecologic cancer

H Yoshida, D Shintani, N Kawashima… - J. BUON Off. J. Balk …, 2020 - jbuon.com
Purpose: Since older age is a risk factor for chemotherapy toxicities, a prediction tool that
can accurately identify older patients who are at risk for toxicity is necessary. The Cancer …

Prospektive Validierung des Erlangen Index als präoperatives geriatrisches Assessment zur Beurteilung des postoperativen Outcome großer urologischer Eingriffe

J Lutz - 2024 - opus.bibliothek.uni-wuerzburg.de
Die Gesellschaft altert und es erhalten vermehrt geriatrische Patienten radikale urologische
Eingriffe. Alte Patienten haben im Rahmen derartiger Operationen ein erhöhtes Risiko …

[HTML][HTML] Toxicidad relacionada con el tratamiento para el cáncer en adultos mayores. Revisión de la literatura

L Beracasa Caro, CA Pardo Barón, JO Sánchez - Universitas Medica, 2021 - scielo.org.co
Las patologías de origen tumoral son más frecuentes en la población adulta mayor; no
obstante, el que dicha población tenga menos oportunidades de acceder a estudios …

[PDF][PDF] Lebensqualität evaluieren und stabilisieren: Assessments als Basis multiprofessioneller Behandlung onkologischer Patient* innen

HB Schmidt - 2021 - d-nb.info
Im Rahmen dieser kumulativen Habilitationsschrift mit dem Thema „Lebensqualität
evaluieren und stabilisieren–Assessments als Basis multiprofessioneller Behandlung …